Search research articles
Contact Us
Filters
Showing results (81-90 of 87) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 87 results.
Cancer Investigation
|
April 8, 2025
A Phase I Study of the Naturally Occurring Bioactive, Opioid Growth Factor, in Patients with Unresectable Hepatocellular Cancer
Eric T Kimchi, Jussuf T Kaifi, Yixing Jiang, et al.
JCO Precision Oncology
|
April 13, 2022
Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules
Yariswamy Manjunath, Kanve Nagaraj Suvilesh, Jonathan B Mitchem, et al.
Gastroenterology
|
February 7, 2018
Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice
Guangfu Li, Dai Liu, Eric T Kimchi, et al.
Molecular Cancer
|
March 13, 2022
Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses
Kanve N Suvilesh, Yulia I Nussbaum, Vijay Radhakrishnan, et al.
Journal of Hepatology
|
August 14, 2016
Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model
Guangfu Li, Dai Liu, Timothy K Cooper, et al.
Cancer Biology & Therapy
|
March 26, 2015
Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques
Jussuf T Kaifi, Miriam Kunkel, Avisnata Das, et al.
Hepatology (Baltimore, Md.)
|
September 8, 2011
Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model
Diego M Avella, Guangfu Li, Todd D Schell, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 87) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 87 results.
Cancer Investigation
|
April 8, 2025
A Phase I Study of the Naturally Occurring Bioactive, Opioid Growth Factor, in Patients with Unresectable Hepatocellular Cancer
Eric T Kimchi, Jussuf T Kaifi, Yixing Jiang, et al.
JCO Precision Oncology
|
April 13, 2022
Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules
Yariswamy Manjunath, Kanve Nagaraj Suvilesh, Jonathan B Mitchem, et al.
Gastroenterology
|
February 7, 2018
Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice
Guangfu Li, Dai Liu, Eric T Kimchi, et al.
Molecular Cancer
|
March 13, 2022
Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses
Kanve N Suvilesh, Yulia I Nussbaum, Vijay Radhakrishnan, et al.
Journal of Hepatology
|
August 14, 2016
Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model
Guangfu Li, Dai Liu, Timothy K Cooper, et al.
Cancer Biology & Therapy
|
March 26, 2015
Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques
Jussuf T Kaifi, Miriam Kunkel, Avisnata Das, et al.
Hepatology (Baltimore, Md.)
|
September 8, 2011
Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model
Diego M Avella, Guangfu Li, Todd D Schell, et al.
Page
of 9